Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Blood Advances|October 19, 2021
Defibrotide: real-world management of veno-occlusive disease/sinusoidal obstructive syndrome after stem cell transplantMary Nauffal, Haesook T Kim, Paul G Richardson, et al.
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-versus-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 13, 2011
The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantationKarim E Abou-Nassar, Haesook T Kim, Jeff Blossom, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 28, 2010
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndromeJohn Koreth, Melinda Biernacki, Julie Aldridge, et al.
Blood|August 29, 2009
Bortezomib, tacrolimus, and methotrexate for prophylaxis of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation from HLA-mismatched unrelated donorsJohn Koreth, Kristen E Stevenson, Haesook T Kim, et al.
Blood Advances|February 24, 2026
No clear benefit of cellular therapy consolidation for patients achieving remission after post-HCT AML relapseH Moses Murdock, Haesook T Kim, Katie Maurer, et al.
Genome Research|October 19, 2004
Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi libraryJean-François Rual, Julian Ceron, John Koreth, et al.
American Journal of Hematology|February 20, 2014
White blood cell recovery after allogeneic hematopoietic cell transplantation predicts clinical outcomeHaesook T Kim, David Frederick, Philippe Armand, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantationVincent T Ho, Haesook T Kim, Julie Aldridge, et al.
Transplantation and Cellular Therapy|September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center ExperienceKuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Pageof 19